A detailed history of Aqr Capital Management LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 564,113 shares of IRWD stock, worth $1.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
564,113
Previous 684,578 17.6%
Holding current value
$1.99 Million
Previous $4.46 Million 48.06%
% of portfolio
0.0%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.93 - $7.04 $473,427 - $848,073
-120,465 Reduced 17.6%
564,113 $2.32 Million
Q2 2024

Aug 14, 2024

BUY
$5.58 - $8.61 $1.2 Million - $1.85 Million
214,836 Added 45.73%
684,578 $4.46 Million
Q1 2024

May 15, 2024

BUY
$8.32 - $15.45 $3.23 Million - $5.99 Million
387,941 Added 474.25%
469,742 $4.09 Million
Q4 2023

Feb 14, 2024

SELL
$8.79 - $11.51 $1.07 Million - $1.4 Million
-121,768 Reduced 59.82%
81,801 $935,000
Q3 2023

Nov 14, 2023

SELL
$8.25 - $11.35 $4.44 Million - $6.1 Million
-537,870 Reduced 72.54%
203,569 $1.96 Million
Q2 2023

Aug 14, 2023

BUY
$10.1 - $11.6 $613,443 - $704,549
60,737 Added 8.92%
741,439 $7.89 Million
Q1 2023

May 15, 2023

BUY
$10.37 - $12.56 $223,006 - $270,102
21,505 Added 3.26%
680,702 $7.16 Million
Q4 2022

Feb 14, 2023

BUY
$9.9 - $12.43 $819,809 - $1.03 Million
82,809 Added 14.37%
659,197 $8.17 Million
Q3 2022

Nov 14, 2022

BUY
$10.14 - $12.38 $1.25 Million - $1.53 Million
123,716 Added 27.33%
576,388 $5.97 Million
Q2 2022

Aug 15, 2022

BUY
$11.05 - $12.72 $5,315 - $6,118
481 Added 0.11%
452,672 $5.22 Million
Q1 2022

May 16, 2022

BUY
$10.61 - $12.88 $244,666 - $297,012
23,060 Added 5.37%
452,191 $5.69 Million
Q4 2021

Feb 14, 2022

BUY
$10.86 - $13.95 $996,578 - $1.28 Million
91,766 Added 27.2%
429,131 $5 Million
Q3 2021

Nov 15, 2021

SELL
$11.92 - $13.92 $1.47 Million - $1.72 Million
-123,323 Reduced 26.77%
337,365 $4.41 Million
Q2 2021

Aug 16, 2021

SELL
$10.16 - $13.11 $810,615 - $1.05 Million
-79,785 Reduced 14.76%
460,688 $5.93 Million
Q1 2021

May 17, 2021

BUY
$9.04 - $11.86 $1.76 Million - $2.31 Million
195,106 Added 56.49%
540,473 $6.04 Million
Q4 2020

Feb 16, 2021

BUY
$9.05 - $12.2 $548,900 - $739,954
60,652 Added 21.3%
345,367 $3.93 Million
Q3 2020

Nov 16, 2020

SELL
$8.99 - $10.74 $1.4 Million - $1.68 Million
-156,206 Reduced 35.43%
284,715 $2.56 Million
Q2 2020

Aug 17, 2020

BUY
$9.14 - $11.97 $1.57 Million - $2.05 Million
171,531 Added 63.67%
440,921 $4.55 Million
Q1 2020

May 15, 2020

BUY
$8.58 - $14.01 $1.05 Million - $1.71 Million
122,277 Added 83.12%
269,390 $2.72 Million
Q4 2019

Feb 14, 2020

BUY
$8.22 - $14.0 $779,831 - $1.33 Million
94,870 Added 181.59%
147,113 $1.96 Million
Q3 2019

Nov 14, 2019

SELL
$8.59 - $10.96 $838,770 - $1.07 Million
-97,645 Reduced 65.15%
52,243 $449,000
Q2 2019

Aug 14, 2019

BUY
$9.8 - $12.89 $947,846 - $1.25 Million
96,719 Added 181.91%
149,888 $1.64 Million
Q1 2019

May 14, 2019

BUY
$8.27 - $12.73 $439,707 - $676,841
53,169 New
53,169 $719,000
Q1 2018

May 15, 2018

SELL
$11.13 - $13.63 $149,019 - $182,492
-13,389 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$12.16 - $14.58 $171,565 - $205,709
-14,109 Reduced 51.31%
13,389 $201,000
Q3 2017

Nov 14, 2017

BUY
$12.07 - $14.87 $331,900 - $408,895
27,498
27,498 $434,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $539M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.